ProPhase Labs, Inc. Payments for Repurchase of Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ProPhase Labs, Inc. payments for repurchase of equity for the quarter ending 2012-12-31 was $0.00.
- ProPhase Labs, Inc. payments for repurchase of equity for the quarter ending 2011-12-31 was $0.00.
- ProPhase Labs, Inc. payments for repurchase of equity for the quarter ending 2010-12-31 was $0.00.
- ProPhase Labs, Inc. payments for repurchase of equity for fiscal 2013 was $0.00.
- ProPhase Labs, Inc. payments for repurchase of equity for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- ProPhase Labs, Inc. payments for repurchase of equity for fiscal 2011 was $449.00K.
- ProPhase Labs, Inc. payments for repurchase of equity for fiscal 2010 was $0.00.
| Period end | Payments for Repurchase of Equity 3 month | Payments for Repurchase of Equity 12 month |
|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-27 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $0.00 10-K · filed 2014-03-27 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $449.00K 10-K · filed 2014-03-27 |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $0.00 10-K · filed 2013-03-28 |
| 2009-12-31 | $0.00 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |